Midazolam for seizures: Buccal administration

Similar documents
Document Details Guidance For The Use Of Emergency Rescue Medication for Children With Epilepsy (Administration Of Buccolam)

Complex Care Hub Manual: Caring for a Child with Epilepsy/Seizures

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics

CONVULSIONS - AFEBRILE

POLICY FOR ADMINSTRATION OF EMERGENCY MEDICATION FOR EPILEPSY

Administering Rescue Medication into Children for Prolonged Seizures

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

Part 1 Principles and Routes of Medication Administration

Rescue medications. What are rescue medications? Ideal rescue medication. Why use rescue medications?

A Comparison of Buccal Midazolam and Intravenous Diazepam for the Acute Treatment of Seizures in Children

Buccal Midazolam For the treatment of prolonged epileptic seizures, clusters of epileptic seizures and status epilepticus.

Rectal Diazepam Rescue Medication

Factsheet. Buccolam (midazolam) 10mg in 2mL oromucosal solution. Management of seizures in adult patients

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Information Sheet

2008 EAGLES PRESENTATION. Intranasal Versed Usage in an Urban Fire Based EMS System: PARAMEDIC PERCEPTION OF UTILITY

MANAGEMENT OF PUPILS WITH EPILEPSY AND EMERGENCY MEDICATION POLICY

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

Midazolam Injection Midazolam

Division 1 Introduction to Advanced Prehospital Care

First aid for seizures

CHILDREN S SERVICES. Trust Medicines Policy and Procedures Paediatric Pain Assessment Chart

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

PATIENT INFORMATION LEAFLET. MIDORYX (MIDAZOLAM INJECTION 5mg, 10mg BP)

5/23/14. Febrile seizures: Who need further workup? Afebrile seizures: Who needs imaging? Status epilepticus: Most effective treatments

Eloxatin Oxaliplatin concentrated solution for injection

Package leaflet: Information for the user. BUCCOLAM 2.5 mg oromucosal solution For children aged 3 months to less than 1 year

ZADITEN Eye Drops 1.0%

MND Just in Case kit Information for GPs

Epilepsy Care Plan. Name. Date of Birth. Address. Telephone. Example Epilepsy Management Plan. Epilepsy Care Plan date

How to Prevent an Opioid Overdose

Cardiac Catheter Labs Intravenous Drug Therapy Guide

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

Outline. What is a seizure? What is epilepsy? Updates in Seizure Management Terminology, Triage & Treatment

SH CP 04. Version: 5. Summary: How to train in administering and administer buccal midazolam for tonic - clonic status epilepticus.

GUIDELINE FOR THE MANAGEMENT OF

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Routes of drug administration

Managing Your Pain After Day Surgery

This leaflet answers some common questions about ATIVAN. It does not contain all of the available information.

The fitting child. Dr Chris Bird MRCPCH DTMH, Locum consultant, Paediatric Emergency Medicine

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

TEMGESIC Injection Buprenorphine (as hydrochloride)

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

SMART STEPS towards a tobacco-free life

Sedation in Children

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain

PATIENT GROUP DIRECTION (PGD)

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

Administrating Medications with the MAD Device

Perjeta Contains the active ingredient pertuzumab (rch)

Medication Guide BELBUCATM (bel-bue-kuh) (buprenorphine) buccal film, CIII BELBUCA is:

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Ophthalmology. Cataract Surgery. Post-operative Information

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

CIPROXIN HC Ear Drops

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Instructions for Patients Following Vitreoretinal Surgery Who Need to Posture

COUNTY OF SACRAMENTO EMERGENCY MEDICAL SERVICES AGENCY

FAIRFIELD SCHOOL HEALTH PROGRAM. PROCEDURE: Administration of Oral, Topical or Inhalant Medications by Principals and Teachers

HOW TO USE YOUR INSTANYL SINGLE-DOSE NASAL SPRAY

Shopping List for Knee Arthroscopy

PATIENT INFORMATION INCRUSE ELLIPTA

Braintree Public Schools

Stop the Status: Improving Outcomes in Pediatric Epilepsy Syndromes. Michelle Welborn, PharmD ICE Alliance

Naloxone Standing Order for Opioid Overdose

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

CRINONE 8% Progesterone 90 mg, Prolonged Release Vaginal gel with Polyethylene applicator

Management of medical emergencies for the dental team

FLIXONASE NASULE DROPS Fluticasone propionate

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to children who have prolonged epilepsy seizures

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Monitor and treat respiratory depression and sedation with supportive emergency measures.

CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH

BrinzoQuin Eye Drops 1.0%

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

NALOXONE CAN BE A LIFESAVER

NOVEL INFLUENZA A (H1N1) Swine Flu

Ceclor CD cefaclor monohydrate sustained release tablets

Mycamine Micafungin (as sodium)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol

NASSAU REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE

Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy?

Intranasal/Oral Midazolam use: Opportunity for Health Intervention when faced with Challenging Behaviours

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to adults who have prolonged epilepsy seizures

Less pain in my life helps me get back to living.

Hydrocortisone advice for parents

End of life prescribing guidance

BISOLVON Chesty Forte.

Sirolimus 1mg/1ml oral solution

Ventolin Injection 500 micrograms/ml salbutamol sulfate

LGP CLASSIC Oil Products

AUGMENTIN is also used to prevent infection from major surgery.

Intranet version. Bradford Teaching Hospitals. NHS Foundation Trust. Having a Gastroscopy. Gastroenterology Unit patient information booklet

Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum)

FLIXONASE NASULE DROPS

contains the active ingredient diazepam It does not contain all the available information.

Transcription:

Midazolam for seizures: Buccal administration Rationale Buccal Midazolam is a convenient and efficient method used to treat prolonged seizures and status epilepticus in children. It can be used in hospital by trained staff, by paramedics, and carers in the home. Buccal Midazolam is absorbed directly into the blood stream through the lining of the cheek. Swallowing Midazolam is not recommended as it is not absorbed as well through the stomach. Introduction Midazolam is a benzodiazepine with anti-seizure properties. Like other benzodiazepines, the properties of midazolam mean that is crosses mucosal surfaces at a fixed and rapid rate and is therefore effective. Where to get it from? Plastic ampules of midazolam can be obtained on a private prescription from community pharmacies, but it is not available on PBS. It is recommended that carers source the plastic ampoule from their community pharmacy. These ampoules may need to be ordered in from the company Pfizer Australia. Ampoules need to be protected from light and discarded eight months after opening the foil pack. In the warmer months when transporting Midazolam ampoules, please keep them in a cool insulated pack to ensure they are kept at a temperature less than 25 degrees. As part of the provision of education to families in the use of midazolam, parents are advised to undertake accredited basic life support training, such as that provided by St Johns Ambulance and The Red Cross and Royal Life Saving. Approved situations It is recommended that buccal midazolam be used in the emergency management of prolonged seizures where venous access cannot be obtained. Situations where the use of buccal midazolam is appropriate or acceptable Treatment of patients for seizures in the ED when an IV route has not been established. Treatment of seizures by parents and carers.

Carers must be given written and diagrammatic instructions (e.g. Epilepsy Association leaflet) and be shown how to administer the medication before they have been discharged or when they attend clinic. Dose: Up to 0.3 mg/kg per dose via the buccal route, maximum single dose 10mg. Your doctor will have instructed you the correct dose you need to give and whether a second dose is appropriate. How to administer buccal midazolam Always keep the snap lock container with the midazolam and syringes etc. in an accessible place, but out of reach of children! Position the patient on their side in the recovery position and prevent injury by moving things away from the child. Time the seizure. With the IV formulations (5mg/1ml) withdraw the dose that has been prescribed for your child from the plastic ampoule. Your child s doctor or Epilepsy nurse should have shown you how much to draw up into the syringe. Open the child s lips and slowly squeeze the solution into the buccal cavity (into the inside of the lower cheek, closest to the ground) between the gum and cheek until the amount is delivered. Gently rub the exterior of the cheek to massage it into the mucosa. After giving the midazolam: Keep the patient in the recovery position and stay with them! Watch the child s breathing and seizure activity while keeping them on their side. Once the seal is broken on the Midazolam ampoule it must be safely discarded. Write down when and how much midazolam was given. Call an ambulance: If you are in any doubt about what to do. If the patient suffers a serious injury while having the seizure. Or if your doctor has given you instructions to do so. Not all children will need an ambulance.

Side effects of midazolam: Midazolam has a sedative effect and your child may be sleepy for some time afterwards. Headache, nausea, vomiting, coughing, and hiccups may occur after giving the Midazolam. Your child may have shallow or slow breathing (respiratory depression) after midazolam. If this occurs call an ambulance and if needed give mouth to mouth resuscitation if your child stops breathing. Basic Life support courses are listed on the PENNSW site under the safety heading. It is advisable that families with children know first aid and how to give rescue breaths in an emergency. Points to remember: Use the plastic ampoules containing 5 mg midazolam in 1 ml NOT glass ampoules or plastic ampoules of other sizes or strengths. The plastic ampoules are produced by Pzifer Australia and can be ordered by your local pharmacy. Midazolam needs to travel where your child goes in case of a seizure when away from home. However it must be given by a trained person in the prescribed manner. Never expect someone who has not been trained to administer it. It is important to follow your doctor s advice on: when and how to give midazolam, when to call an ambulance, and when to take your child to hospital. Midazolam must be stored at normal room temperature (below 25 degrees Celsius) Midazolam should be protected from light (wrapped in foil). Note the date that the midazolam is taken out of the prescribing box and wrapped in foil, as it needs to be discarded 8 months after exposure to light. ALWAYS keep Midazolam locked away and out of the reach of children and keep in a snap lock type container. This is a guide only. Your Epilepsy First Aid Management Plan has been written by your doctor and / or Epilepsy nurse and should be followed.

Midazolam for seizures: Intra-nasal administration Rationale Intra-nasal Midazolam is a convenient and efficient method used to treat prolonged seizures and status Epilepticus in children. It can be used in hospital by trained staff, paramedics and carers in the home. Intra-nasal Midazolam is absorbed directly into the blood stream through the lining of the nasal passage. Swallowing Midazolam is not recommended as it is not absorbed as well through the stomach. Introduction Midazolam is a benzodiazepine with anti-seizure properties. Like other benzodiazepines, the properties of midazolam mean that is crosses mucosal surfaces at a fixed and rapid rate and is therefore effective. Where to get it from? Plastic ampules of midazolam can be obtained on a private prescription from community pharmacies, but it is not available on PBS. It is recommended that carers source the plastic ampoule from their community pharmacy. These ampoules may need to be ordered in from the company Pfizer Australia. Ampoules need to be protected from light and discarded eight months after opening the foil pack. In the warmer months when transporting Midazolam ampoules, please keep them in a cool insulated pack to ensure they are kept at a temperature less than 25 degrees. As part of the provision of education to families in the use of midazolam, parents are advised to undertake accredited basic life support training, such as that provided by St Johns Ambulance and The Red Cross. Approved situations It is recommended that intra-nasal midazolam be used in the emergency management of prolonged seizures where venous access cannot be obtained and there are too many secretions to use buccal midazolam.

Situations where the use of intra-nasal midazolam is appropriate or acceptable: Treatment of patients for seizures in the ED when an IV route has not been established. Treatment of seizures by parents and carers. Where, for some reason the family have been instructed to use Intra-nasal instead of Buccal Midazolam. Carers must be given written and diagrammatic instructions (e.g. Epilepsy Association leaflet) and be shown how to administer the medication before they have been discharged or when they attend clinic. Dose: Up to 0.3 mg/kg per dose via the intra-nasal route, maximum single dose 10mg. Your doctor will have instructed you the correct dose you need to give and whether a second dose is appropriate. How to administer intra-nasal midazolam Always keep the snap lock container with the midazolam and syringes etc. in an accessible place but out of reach of children! Position the patient on their side in the recovery position and prevent injury by moving things away from the child. Time the seizure. With the IV formulations (5mg/1ml) withdraw the dose that has been prescribed for your child from the plastic ampoule. Your child s doctor or Epilepsy nurse should have shown you how much to draw up into the syringe. Slightly tilt the patients head. This may require a pillow under the shoulders. To administer, hold the ampoule or syringe over the nostril and gently squeeze and drip Midazolam, 2 to 3 drops at a time, into one nostril and then the other. Once done, ensure your child is safe and if necessary place on their side to facilitate breathing. After giving the midazolam: Keep the patient in the recovery position and stay with them! Watch the child s breathing and seizure activity while keeping them on their side. Once the seal is broken on the Midazolam ampoule it must be safely discarded. Write down when and how much midazolam was given.

Call an ambulance: If you are in any doubt of what to do. If a serious injury has occurred to the patient while they had the seizure. Or if your doctor has given you instructions to do so. Not all children will need an ambulance. Side effects of midazolam: Midazolam has a sedative effect and your child may be sleepy for some time afterwards. Headache, nausea, vomiting, coughing, and hiccups may occur after giving the Midazolam. Your child may have shallow or slow breathing (respiratory depression) after midazolam. If this occurs call an ambulance and if needed give mouth to mouth resuscitation if your child stops breathing. Basic Life support courses are recommended on the PENNSW site under the safety heading. It is advisable that families with children know first aid and how to give rescue breaths in an emergency. Points to remember: Use the plastic ampoules containing 5 mg midazolam in 1 ml NOT glass ampoules or plastic ampoules of other sizes or strengths. The plastic ampoules are produced by Pzifer Australia and can be ordered by your local pharmacy. Midazolam needs to travel where your child goes in case of a seizure when away from home. However it must be given by a trained person in the prescribed manner. Never expect someone who has not been trained to administer it. It is important to follow your doctor s advice on: when and how to give midazolam, when to call an ambulance, and when to take your child to hospital. Midazolam must be stored at normal room temperature (below 25 degrees Celsius). Midazolam should be protected from light (wrapped in foil). Note the date that the midazolam is taken out of the prescribing box and wrapped in foil, as it needs to be discarded 8 months after exposure to light. ALWAYS keep Midazolam locked away and out of the reach of children and keep in a snap lock type container. This is a guide only. Your Epilepsy First Aid Management Plan has been written by your doctor and / or Epilepsy nurse and should be followed.

References 1.Mims Online [Internet]. St Leonards, NSW: UBM Medica; 2013. Midazolam [Last updated 21/03/2012 ; Accessed 04/06/2013]; Available from: https://www.mimsonline.com.au.acs.hcn.com.au/search/fullpi.aspx?modulename=product Info&searchKeyword=midazolam&PreviousPage=~/Search/QuickSearch.aspx&SearchType= &ID=61040001_ 2. Therapeutic Guidelines: Neurology Version 4: 2011 3. NSW Ministry of Health Policy Directive 2009_065. Children and Infants with Seizures - Acute Management Clinical [internet] [April 2009; Accessed May 2013] Available from: http://www0.health.nsw.gov.au/policies/pd/2009/pd2009_065.html 4. Body R, Ijaz M. Best Evidence Topic Report. Buccal midazolam as an alternative to rectal midazolam for prolonged seizures in childhood and adolescence. Emerg Med J 2005;22:364-5 5. Baysun S, Aydin OF et al. A comparison of buccal midazolam and rectal diazepam for acute treatment of seizures. Clinical Pediatrics 2005;44 (9):771-6. 6. Lahat E, Goldman M, Barr J, et al: Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. Br Med J 2000a; 321:83-86 7. Scott SC et al Buccal midazolam should be preferred to nasal midazolam [letter] BMJ 2001;322:107. 8. Wilson MT et al. Nasal/buccal midazolam use in the community. Arch Dis Child 2004;89(1):50-1. 9. Wiznitzer M Buccal midazolam for seizures Lancet 2005;366:182-3 10. Scott RC et al Buccal administration of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia 1998;39:290-4. 11. McIntyre J et al Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366:205-10. 12. Epilepsy Action Australia Patient information Fact Sheet: Seizure Smart Midazolam Plastic Ampoules [internet] [Updated Jan 2011; Accessed May 2013] Available from: http://www.epilepsy.org.au/sites/default/files/seizure Smart-Midazolam Plastic Ampoules.pdf 13. Royal Children s Hospital, Melbourne Fact Sheet Buccal midazolam [internet] Royal Children s Hospital, Melbourne [Updated September 2012; Accessed May 2013] Available from: http://www.rch.org.au/kidsinfo/factsheets.cfm?doc_id=9300 14. Shinnar S, Berg AT, Moshe SL, et al. How long do new onset seizures in children last? ANN Neurology 2001 49:659-664. 15. Sydney Children s Hospital Guideline Drug Protocol No: 1/C/13:7024-01:00 Drug Protocol: Midazolam for Seizures: Buccal Administration - SCH 16. St Johns Ambulance Course phone 1300 360 455 17. Red Cross Organisation Australia 1300 367 428